4000-520-616
欢迎来到免疫在线!(蚂蚁淘生物旗下平台)  请登录 |  免费注册 |  询价篮
MedKoo(授权代理)
主营:主营:抗癌化学试剂和激酶抑制剂
咨询热线电话
4000-520-616
当前位置: 首页 > 产品中心 > peptide > MedKoo/Chlorin/100mg/500410
商品详细MedKoo/Chlorin/100mg/500410
MedKoo/Chlorin/100mg/500410
MedKoo/Chlorin/100mg/500410
商品编号: 500410
品牌: MedKoo
市场价: ¥1800.00
美元价: 1080.00
产地: 美国(厂家直采)
公司:
产品分类: 多肽合成
公司分类: peptide
联系Q Q: 3392242852
电话号码: 4000-520-616
电子邮箱: info@ebiomall.com
商品介绍

Chlorin E6
featured

WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#:500410

CAS#:19660-77-6

Description:Chlorin E6 is a natural molecule and a promising photosensitizer. Chlorin E6 usually can be made from Live chlorella and other green plants . Chlorin E6 is an attractive photodynamic therapy (PDT) drug candidate because of (1) its high absorption in the red spectral region , and (2) its low cost to make compared to other porphyrin-based PDT drugs . Chlorin E6 exhibits advantageous photophysical properties for PDT such as having long lifetimes in their photoexcited triplet states and high molar absorption in the red region of the visible spectrum. Moreover, a 664-nm laser light can penetrate tissue deeper that the 630-nm laser light used for Photofrin. Chlorin E6 is also an important starting material for making PDT drug Talaporfin sodium (mono-L-aspartyl chlorin e6, NPe6).

Price and Availability

SizePriceShipping out timeQuantity
100mgUSD 90Same day
200mgUSD 150Same day
500mgUSD 250Same day
1gUSD 450Same day
2gUSD 810Same day
5gUSD 1820Same day
Inquire bulk and customized quantity

Pricing updated 2021-01-23.Prices are subject to change without notice.

Chlorin E6, purity > 95%, is in stock. The same day shipping out after order is received.

Chemical Structure

img

Theoretical Analysis

MedKoo Cat#: 500410Name: Chlorin E6CAS#: 19660-77-6Chemical Formula: C34H36N4O6Exact Mass: 596.26348Molecular Weight: 596.67Elemental Analysis:C, 68.44; H, 6.08; N, 9.39; O, 16.09

Synonym:CE6; Chlorin E6; chlorin e6.

IUPAC/Chemical Name:2-[(7S,8S)-3-Carboxy-7-(2-carboxyethyl)-13-ethenyl-18-ethyl-7,8-dihydro-2,8,12,17-tetramethyl-21H,23H-porphin-5-yl]acetic acid

InChi Key:VAJLRIOJDADNAT-HHGNVTQFSA-N

InChi Code:InChI=1S/C34H36N4O6/c1-7-19-15(3)23-12-25-17(5)21(9-10-29(39)40)32(37-25)22(11-30(41)42)33-31(34(43)44)18(6)26(38-33)14-28-20(8-2)16(4)24(36-28)13-27(19)35-23/h7,12-14,17,21,35,38H,1,8-11H2,2-6H3,(H,39,40)(H,41,42)(H,43,44)/b23-12-,24-13-,25-12-,26-14-,27-13-,28-14-,32-22-,33-22-/t17-,21-/m0/s1

SMILES Code:O=C(O)C/C1=C2[C@@H](CCC(O)=O)[C@H](C)C(/C=C3C(C)=C(C=C)/C(N/3)=C/C(C(C)=C/4CC)=NC4=C/C5=C(C)C(C(O)=O)=C1N5)=N2

Technical Data

Appearance:
black solid powder

Purity:
>9 5 % (or refer to the Certificate of Analysis)

Certificate of Analysis:
View CoA: current bath, Lot#FS50113View CoA: current batch, Lot#FS81005

QC Data:
View the optical absorption and fluorescence emission spectrum of Chlorin e6View QC data:  current bath, Lot#FS50113View QC data: current batch, Lot#FS81005

Safety Data Sheet (SDS):
View Safety Data Sheet (SDS)

Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition:
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility:
Soluble in DMSO, not in water

Shelf Life:
>2 years if stored properly

Drug Formulation:
This drug may be formulated in DMSO

Stock Solution Storage:
0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code:
2934.99.9001

Additional Information

Photodynamic therapy (PDT) is currently being used as an alternative therapeutic modality for a variety of malignant tumors. This study was performed to show an efficient preparation of second generation of photosensitizer chlorin e6 (Ce6) with high yield and purity, and to test antitumor activity of Ce6-induced PDT (Ce6-PDT) both in vitro and in vivo using a rat tumor model. Three-week-old male Sprague-Dawley (SD) rats were inoculated s.c. on the right flank with 5x106 RK3E-ras cells. The animals were admin-istered i.v. with Ce6 (10 mg/kg) and 24 h later, PDT was performed using a laser diode at a light dose of 100 J/cm2. Ce6-PDT generated reactive oxygen species and led to significant growth inhibition in RK3E-ras cell. In addition, Ce6-PDT induced apoptosis through the activation of caspase-3 and its downstream target, PARP cleavage. The protein level of anti-apoptotic bcl-2 was also reduced by Ce6-PDT in RK3E-ras cells. In in vivo experiments, application of Ce6-PDT led to a significant reduction of tumor size. PCNA immunostaining and TUNEL assay revealed that Ce6-PDT inhibited tumor cell proliferation and increased apoptosis. These findings suggest that the newly purified Ce6-PDT can effectively arrest tumor growth by inhibiting cell proliferation and inducing apoptosis.  ( source: Oncology Reports, 2009, 22(5). 1085-1091. Doi: 10.3892/or_00000540. Efficient preparation of highly pure chlorin e6 and its photodynamic anti-cancer activity in a rat tumor model. Authors: Yeon-Hee Moon, Seong-Min Kwon, Hyo-Jun Kim, Kwan-Young Jung, Jong-Hwan Park, Soo-A Kim, Yong-Chul Kim, Sang-Gun Ahn, Jung-Hoon Yoon. Affiliations: Department of Pathology, School of Dentistry, Chosun University, Gwangju 500-759, Korea, http://www.spandidos-publications.com/or/22/5/1085 ).Photodynamic therapy (PDT) is currently being used as an alternative therapeutic modality for a variety of malignant tumors. This study was performed to show an efficient preparation of second generation of photosensitizer chlorin e6 (Ce6) with high yield and purity, and to test antitumor activity of Ce6-induced PDT (Ce6-PDT) both in vitro and in vivo using a rat tumor model. Three-week-old male Sprague-Dawley (SD) rats were inoculated s.c. on the right flank with 5x106 RK3E-ras cells. The animals were admin-istered i.v. with Ce6 (10 mg/kg) and 24 h later, PDT was performed using a laser diode at a light dose of 100 J/cm2. Ce6-PDT generated reactive oxygen species and led to significant growth inhibition in RK3E-ras cell. In addition, Ce6-PDT induced apoptosis through the activation of caspase-3 and its downstream target, PARP cleavage. The protein level of anti-apoptotic bcl-2 was also reduced by Ce6-PDT in RK3E-ras cells. In in vivo experiments, application of Ce6-PDT led to a significant reduction of tumor size. PCNA immunostaining and TUNEL assay revealed that Ce6-PDT inhibited tumor cell proliferation and increased apoptosis. These findings suggest that the newly purified Ce6-PDT can effectively arrest tumor growth by inhibiting cell proliferation and inducing apoptosis.  ( source: Oncology Reports, 2009, 22(5). 1085-1091.Doi: 10.3892/or_00000540.Efficient preparation of highly pure chlorin e6 and its photodynamic anti-cancer activity in a rat tumor model. Authors: Yeon-Hee Moon, Seong-Min Kwon, Hyo-Jun Kim, Kwan-Young Jung, Jong-Hwan Park, Soo-A Kim, Yong-Chul Kim, Sang-Gun Ahn, Jung-Hoon Yoon. Affiliations: Department of Pathology, School of Dentistry, Chosun University, Gwangju 500-759, Korea, http://www.spandidos-publications.com/or/22/5/1085 ).        Methods to make Chlorin E6make Chlorin E6Chlorin E6 is a natural product, and usually can be made from Live chlorella (Chlorella ellipsoidea, see the following pictures)Chlorin E6 is a natural product, and usually can be made from Live chlorella (Chlorella ellipsoidea, see the following pictures)              The following procedure was reported in Oncology Reports, 2009, 22(5). 1085-1091 by Korean scientists Yeon-Hee Moon et al.   Live chlorella (Chlorella ellipsoidea) 100 g (dried weight) was sequentially washed with 500 ml of water and 300 ml of 50% ethanol in water to remove polar materials and the residue was extracted twice with 500 ml of 100% ethanol to obtain chlorophyll a rich fraction (extraction yield 4.3%). Stirring the combined ethanol solution of chlorophyll a in 1 N HCl (pH 2.5) for 3 h at room temperature afforded pheophytin in the form of precipitates. The precipitate was dissolved in dichloromethane washed with distilled water, dried with anhydrous sodium sulfate, and rotary-evaporated to dryness. The residue was purified by a chromatography using neutral alumina (Aldrich, Brockmann, ~150 mesh) with a gradient elution from 30% dichloromethane in n-hexane to 100% dichloromethane. The main green band was collected and evaporated to dryness. The crystalline powder was dissolved in acetone, adjusted pH 12.0 with 1 N NaOH, and stirred for 12 h. The precipitated Ce6 was filtered, washed with acetone and dissolved in 100 ml of water, and filtered to remove insoluble impurity. After lyophilization of the filtered water solution, a fine black powder of Ce6 was obtained. The purity of Ce6 is 93-98% (yield of Ce6: 1% from dried weight of chlorella).The following procedure was reported in Live chlorella (Chlorella ellipsoidea) 100 g (dried weight) was sequentially washed with 500 ml of water and 300 ml of 50% ethanol in water to remove polar materials and the residue was extracted twice with 500 ml of 100% ethanol to obtain chlorophyll a rich fraction (extraction yield 4.3%). Stirring the combined ethanol solution of chlorophyll a in 1 N HCl (pH 2.5) for 3 h at room temperature afforded pheophytin in the form of precipitates. The precipitate was dissolved in dichloromethane washed with distilled water, dried with anhydrous sodium sulfate, and rotary-evaporated to dryness. The residue was purified by a chromatography using neutral alumina (Aldrich, Brockmann, ~150 mesh) with a gradient elution from 30% dichloromethane in n-hexane to 100% dichloromethane. The main green band was collected and evaporated to dryness. The crystalline powder was dissolved in acetone, adjusted pH 12.0 with 1 N NaOH, and stirred for 12 h. The precipitated Ce6 was filtered, washed with acetone and dissolved in 100 ml of water, and filtered to remove insoluble impurity. After lyophilization of the filtered water solution, a fine black powder of Ce6 was obtained. The purity of Ce6 is 93-98% (yield of Ce6: 1% from dried weight of chlorella).    

References

1: Li Q, Wang X, Wang P, Zhang K, Wang H, Feng X, LiuQ. Efficacy of Chlorin e6-Mediated Sono-Photodynamic Therapy on 4T1Cells. Cancer Biother Radiopharm. 2013 Nov 9. [Epub ahead of print]PubMed PMID: 24206161.

2: Li Z, Wang C, Cheng L, Gong H, Yin S, Gong Q, Li Y, Liu Z.PEG-functionalized iron oxide nanoclusters loaded with chlorin e6 fortargeted, NIR light induced, photodynamic therapy. Biomaterials. 2013Dec;34(36):9160-70. doi: 10.1016/j.biomaterials.2013.08.041. Epub 2013Sep 3. PubMed PMID: 24008045.

3: Skripka A, Valanciunaite J, Dauderis G, Poderys V, Kubiliute R,Rotomskis R. Two-photon excited quantum dots as energy donors forphotosensitizer chlorin e6. J Biomed Opt. 2013 Jul;18(7):078002. doi:10.1117/1.JBO.18.7.078002. PubMed PMID: 23864017.

4: Wang H, Wang X, Wang P, Zhang K, Yang S, Liu Q. Ultrasound enhancesthe efficacy of chlorin E6-mediated photodynamic therapy in MDA-MB-231cells. Ultrasound Med Biol. 2013 Sep;39(9):1713-24. doi:10.1016/j.ultrasmedbio.2013.03.017. Epub 2013 Jul 3. PubMed PMID:23830103.

5: Kimani S, Ghosh G, Ghogare A, Rudshteyn B, Bartusik D, Hasan T, GreerA. Synthesis and characterization of mono-, di-, and tri-poly(ethyleneglycol) chlorin e6 conjugates for the photokilling of human ovariancancer cells. J Org Chem. 2012 Dec 7;77(23):10638-47. doi:10.1021/jo301889s. Epub 2012 Nov 14. PubMed PMID: 23126407; PubMedCentral PMCID: PMC3815657.

6: Chen B, Zheng R, Liu D, Li B, Lin J, Zhang W. The tumor affinity ofchlorin e6 and its sonodynamic effects on non-small cell lung cancer.Ultrason Sonochem. 2013 Mar;20(2):667-73. doi:10.1016/j.ultsonch.2012.09.008. Epub 2012 Oct 2. PubMed PMID: 23073382.

7: Saboktakin MR, Tabatabaie RM, Amini FS, Maharramov A, Ramazanov MA.Synthesis and in-vitro photodynamic studies of the superparamagneticchitosan hydrogel/chlorin E6 nanocarriers. Med Chem. 2013Feb;9(1):112-7. PubMed PMID: 22762166.

8: Li P, Zhou G, Zhu X, Li G, Yan P, Shen L, Xu Q, Hamblin MR.Photodynamic therapy with hyperbranched poly(ether-ester) chlorin(e6)nanoparticles on human tongue carcinoma CAL-27 cells. PhotodiagnosisPhotodyn Ther. 2012 Mar;9(1):76-82. doi: 10.1016/j.pdpdt.2011.08.001.Epub 2011 Oct 4. PubMed PMID: 22369732; PubMed Central PMCID:PMC3292741.

9: Shim G, Lee S, Kim YB, Kim CW, Oh YK. Enhanced tumor localization andretention of chlorin e6 in cationic nanolipoplexes potentiate the tumorablation effects of photodynamic therapy. Nanotechnology. 2011 Sep7;22(36):365101. doi: 10.1088/0957-4484/22/36/365101. Epub 2011 Aug 12.PubMed PMID: 21841215.

10: Shi H, Liu Q, Qin X, Wang P, Wang X. Pharmacokinetic study of anovel sonosensitizer chlorin-e6 and its sonodynamic anti-cancer activityin hepatoma-22 tumor-bearing mice. Biopharm Drug Dispos. 2011Sep;32(6):319-32. doi: 10.1002/bdd.761. Epub 2011 Aug 3. PubMed PMID:21815170.

品牌介绍
MedKoo 美帝药库公司以药物化学合成技术为核心,密切结合全球抗癌新药研发领域中的新技术、新理论、新趋势和新的发展方向,不断推出抗癌化合物新品种。 。 美帝药库MedKoo将在中国建立药物化学合成生产基地和多个现代化药物化合物存储仓库。 美帝药库的药物化合物来源于以下几个渠道:自主合成、委托化学合成、合作伙伴、和从国内外市场上选购。 MedKoo美帝药库的抗癌分子库 MedKoo的目标是打造全球规模最大、品种最多、类别最全和质量最好的小分子抗癌化合物库。MedKoo的抗癌药库将由下列5个分子库组成: (1)上市抗癌药库:该库将含有大约100个全球已批准上市的小分子抗癌化合物; (2)抗癌候选药物库:该分子库含有大约400个世界各国正在临床研究中抗癌小分子候选药物; (3)同系抗癌分子库:该分子库将含有多个化学结构类似或抗癌机制类似的分子包; (4)抗癌分子预制模块库:该库主要含有用于组建抗癌目标分子的分子模块包; (5)同位素标记抗癌分子库。